{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:35:00Z","timestamp":1761154500248},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,7,14]],"date-time":"2003-07-14T00:00:00Z","timestamp":1058140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,7,14]],"date-time":"2003-07-14T00:00:00Z","timestamp":1058140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2003,8,1]]},"DOI":"10.1038\/sj.bmt.1704126","type":"journal-article","created":{"date-parts":[[2003,7,14]],"date-time":"2003-07-14T11:05:54Z","timestamp":1058180754000},"page":"299-305","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Autologous tandem transplantation: almost complete reduction of neutropenic fever following the second transplantation by ex vivo expanded autologous myeloid postprogenitor cells"],"prefix":"10.1038","volume":"32","author":[{"given":"A","family":"Reichle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Zaiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Rothe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Andreesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,7,14]]},"reference":[{"key":"BF1704126_CR1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/sj.bmt.1702822","volume":"27","author":"G Reich","year":"2001","unstructured":"Reich G, Mapara MY, Reichardt P et al. Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors. Bone Marrow Transplant 2001; 27: 525\u2013529.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704126_CR2","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/sj.bmt.1702033","volume":"24","author":"M Offidani","year":"1999","unstructured":"Offidani M, Corvatta L, Olivieri A et al. Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF. Bone Marrow Transplant 1999; 24: 1079\u20131087.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704126_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0140-6736(96)90536-X","volume":"347","author":"N Schmitz","year":"1996","unstructured":"Schmitz N, Linch DC, Dreger P et al. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 1996; 347: 353\u2013357.","journal-title":"Lancet"},{"key":"BF1704126_CR4","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood.V91.9.3148","volume":"91","author":"N Ketterer","year":"1998","unstructured":"Ketterer N, Salles G, Raba M et al. High CD34(+) cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation. Blood 1998; 91: 3148\u20133155.","journal-title":"Blood"},{"key":"BF1704126_CR5","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1182\/blood.V86.10.3961.bloodjournal86103961","volume":"86","author":"CH Weaver","year":"1995","unstructured":"Weaver CH, Hazelton B, Birch R et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 86: 3961\u20133969.","journal-title":"Blood"},{"key":"BF1704126_CR6","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1182\/blood.V85.12.3452.bloodjournal85123452","volume":"85","author":"DJ Weisdorf","year":"1995","unstructured":"Weisdorf DJ, Verfaillie CM, Davies SM et al. Hematopoietic growth factors for graft failure after bone marrow transplantation: a randomized trial of granulocyte-macrophage colony- stimulating factor (GM-CSF) versus sequential GM-CSF plus granulocyte- CSF. Blood 1995; 85: 3452\u20133456.","journal-title":"Blood"},{"key":"BF1704126_CR7","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/S0140-6736(99)03113-X","volume":"354","author":"J Reiffers","year":"1999","unstructured":"Reiffers J, Cailliot C, Dazey B et al. Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells. Lancet 1999; 354: 1092\u20131093.","journal-title":"Lancet"},{"key":"BF1704126_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1200\/JCO.2000.18.2.307","volume":"18","author":"ON Koc","year":"2000","unstructured":"Koc ON, Gerson SL, Cooper BW et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000; 18: 307\u2013316.","journal-title":"J Clin Oncol"},{"key":"BF1704126_CR9","first-page":"340","volume":"34","author":"K Possinger","year":"1993","unstructured":"Possinger K, Wilmanns W . Palliative therapeutic control of tumor progression in patients with metastatic breast cancer. Internist (Berl) 1993; 34: 340\u2013350.","journal-title":"Internist (Berl)"},{"key":"BF1704126_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/sj.bmt.1701860","volume":"24","author":"CF Waller","year":"1999","unstructured":"Waller CF, von Lintig F, Daskalakis A, Musahl V, Lange W . Mobilization of peripheral blood progenitor cells in patients with breast cancer: a prospective randomized trial comparing rhG-CSF with the combination of rhG-CSF plus rhEpo after VIP-E chemotherapy. Bone Marrow Transplant 1999; 24: 19\u201324.","journal-title":"Bone Marrow Transplant"},{"key":"BF1704126_CR11","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1182\/blood.V80.6.1405.bloodjournal8061405","volume":"80","author":"DN Haylock","year":"1992","unstructured":"Haylock DN, To LB, Dowse TL et al. Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage. Blood 1992; 80: 1405\u20131412.","journal-title":"Blood"},{"key":"BF1704126_CR12","first-page":"155","volume-title":"Bone Marrow Processing and Purging: A Practical Guide","author":"HJ Sutherland","year":"1991","unstructured":"Sutherland HJ, Eaves AC, Eaves CJ . Quantitative assays for human hematopoietic progenitor cells. In: Gee A (ed.). Bone Marrow Processing and Purging: A Practical Guide. CRC Press Inc.: Boca Raton, 1991, pp. 155\u2013171."},{"key":"BF1704126_CR13","volume-title":"Clonal culture of hematopoietic cells: techniques and applications","author":"D Metcalf","year":"1984","unstructured":"Metcalf D . Clonal culture of hematopoietic cells: techniques and applications. Elsevier: Amsterdam, 1984."},{"key":"BF1704126_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1089\/scd.1.1996.5.213","volume":"5","author":"DR Sutherland","year":"1996","unstructured":"Sutherland DR, Anderson L, Keeney M et al. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 1996; 5: 213\u2013226.","journal-title":"J Hematother"},{"key":"BF1704126_CR15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1006\/immu.1994.1054","volume":"5","author":"J Olweus","year":"1994","unstructured":"Olweus J, Lund Johansen F, Terstappen LW . Expression of cell surface markers during differentiation of CD34+, CD38-\/lo fetal and adult bone marrow cells. Immunomethods 1994; 5: 179\u2013188.","journal-title":"Immunomethods"},{"key":"BF1704126_CR16","first-page":"49","volume-title":"Leukocyte Typing IV","author":"D Piatier-Tonneau","year":"1997","unstructured":"Piatier-Tonneau D . CD4 Workshop Panel report. In: Kishimoto T, Kikutani H, von dem Borne AE, Goyert SM, Mason D, Miyasaka M. (eds.). Leukocyte Typing IV. Garland Publishing: New York, London, 1997, pp. 49\u201354."},{"key":"BF1704126_CR17","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood.V96.7.2385","volume":"96","author":"RL Paquette","year":"2000","unstructured":"Paquette RL, Dergham ST, Karpf E et al. Ex vivo expanded unselected peripheral blood: progenitor cells reduce posttransplantation neutropenia, thrombocytopenia, and anemia in patients with breast cancer. Blood 2000; 96: 2385\u20132390.","journal-title":"Blood"},{"key":"BF1704126_CR18","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1182\/blood.V96.9.3001","volume":"96","author":"I McNiece","year":"2000","unstructured":"McNiece I, Jones R, Bearman SI et al. Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer. Blood 2000; 96: 3001\u20133007.","journal-title":"Blood"},{"key":"BF1704126_CR19","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0301-472X(99)00026-0","volume":"27","author":"S Scheding","year":"1999","unstructured":"Scheding S, Franke H, Diehl V et al. How many myeloid post-progenitor cells have to be transplanted to completely abrogate neutropenia after peripheral blood progenitor cell transplantation? Results of a computer simulation. Exp Hematol 1999; 27: 956\u2013965.","journal-title":"Exp Hematol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1704126","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1704126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:09:03Z","timestamp":1648076943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1704126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7,14]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,8,1]]}},"alternative-id":["BF1704126"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1704126","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7,14]]},"assertion":[{"value":"20 November 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}